Major drug breakthrough to treat Alzheimer’s

Jun 13, 2013 by

A new drug called NitroMemantine has been found to boost brain synapses lost to Alzheimer’s disease. By combining two medicines that are already approved by the FDA, NitroMemantine restores the synapses between neurons. It’s the destruction of these synapses that leads to cognitive decline and memory loss.

In the past, drugs aimed to treat Alzheimer’s disease have addressed the amyloid beta plaques or neurofibrillary tangles – without much success.

But NitroMemantine brings the number of synapses back to normal within just a few months! (These tests are done on mice.) This may bring hope to not only early-stage Alzheimer’s patients, but also those who have experienced the disease’s progression.